--2025/Q1-- / 3.173M--
--2024/Q4-- / 4.238M--
--2024/Q36.865M / 3.256M--
Aug 8, 20242024/Q26.692M / 2.711M--
--2024/Q15.695M / 2.250M--
Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
VERV Verve Therapeutics
- 5.710
- -0.520-8.35%
Close Dec 13 16:00 ET
- 5.810
- +0.100+1.75%
Post 20:02 ET
483.43MMarket Cap-2.32P/E (TTM)
6.115High5.450Low1.46MVolume6.100Open6.230Pre Close8.30MTurnover2.62%Turnover RatioLossP/E (Static)84.66MShares19.34052wk High0.95P/B319.39MFloat Cap4.30552wk Low--Dividend TTM55.94MShs Float78.000Historical High--Div YieldTTM10.67%Amplitude4.305Historical Low5.666Avg Price1Lot Size
Verve Therapeutics Key Stats
Verve Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Verve Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data